Acasti Pharma Inc.
ACST
Rangering i aksjer
#29744
Acasti Pharma Inc. is a biopharmaceutical company dedicated to the research,... Acasti Pharma Inc. is a biopharmaceutical company dedicated to the research, development, and market introduction of pharmaceutical solutions for cardiovascular conditions. The firm is currently exploring strategic collaborations to further the clinical advancement of its compound, CaPre. Established in 2002, Acasti Pharma Inc. maintains its principal operations from its headquarters in Laval, Canada.
Aksjekurs
$0.4256834
Sist synkronisert: 2023-03-27
Markedsverdi
$18.99M
Endring (1 dag)
3.08%
Endring (1 år)
-87.02%
Land
CA
Handel Acasti Pharma Inc. (ACST)
Kategori
Healthcare
P/S-forhold for Acasti Pharma Inc. (ACST)
P/S-forhold per October 2026 TTM: 0.00
Ifølge Acasti Pharma Inc. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 0.00. Ved slutten av 2024 hadde selskapet et P/S-forhold på 0.00.
P/S-historikk for Acasti Pharma Inc. fra 2010 til 2026
P/S-forhold ved hvert års slutt
| År | P/S-forhold | Endre |
|---|---|---|
| 2026 (TTM) | 0.00 | 0.00% |
| 2025 | 0.00 | 0.00% |
| 2024 | 0.00 | 0.00% |
| 2023 | 0.00 | 0.00% |
| 2022 | 0.00 | -100.00% |
| 2021 | 37.95 | 0.00% |
| 2020 | 0.00 | 0.00% |
| 2019 | 0.00 | 0.00% |
| 2018 | 0.00 | 0.00% |
| 2017 | 0.00 | -100.00% |
| 2016 | 32.56 | 746.49% |
| 2015 | 3.85 | 195.83% |
| 2014 | 1.30 | 95.64% |
| 2013 | 0.66 | -98.33% |
| 2012 | 39.84 | 270.24% |
| 2011 | 10.76 | 0.00% |
| 2010 | 0.00 | 0.00% |
P/S-forhold for lignende selskaper eller konkurrenter
| Selskap | P/S-forhold | Forskjell i P/S-forhold | Land |
|---|---|---|---|
| 10.02 | - |
US
|
|
| 40.55 | - |
US
|
|
| 3.96 | - |
AU
|
|
| - | - |
CH
|
|
| 10.15 | - |
NL
|
